Study assigns dollar value to alteplase-streptokinase debate.
D003362:Cost-Benefit Analysis; D016527:Drug Costs; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D010960:Plasminogen Activators / Q000191:economics*; D013300:Streptokinase / Q000191:economics*; D010959:Tissue Plasminogen Activator / Q000191:economics*; D014481:United States / Q000453:epidemiology
D013300:Streptokinase; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator